Agoracom Blog Home

Posts Tagged ‘EKG’

CardioComm Solutions $EKG.ca – Consumers want mobile health #Mhealth convenience $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 11:01 AM on Friday, August 16th, 2019

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

EKG: TSX-V
———————-

Consumers want mobile health convenience

  • According to an article in HealthPayer Intelligence published on May 16, 2018, “Telehealth is a promising opportunity to increase member engagement because a greater number of individuals are open to the use of telehealth services.
  • Telehealth and remote care provide an exceptional customer experience opportunity for payers.

by Mike Greiwe, MD

According to an article in HealthPayer Intelligence published on May 16, 2018, “Telehealth is a promising opportunity to increase member engagement because a greater number of individuals are open to the use of telehealth services. Telehealth and remote care provide an exceptional customer experience opportunity for payers. Consumers want telehealth as a convenient way to receive checkups, preventive care and non-critical services without the need for travel and wait times.”

A study cited by mHealth Intelligence suggests patients are willing, the technology is ready, but clinical providers and insurance payers have lagged behind data that show patients are ready for the convenience found in mobile health applications. Of the 400 consumers surveyed, 77% said they would be more likely to pick a doctor who offered telemedicine applications over one that hadn’t yet adopted the technology. Data showed the reasons behind the interest in mobile health virtual visits included that:

  • Patients want the option of skipping a time-consuming trip to the doctor for a simple recheck or non-urgent visit; and
  •  Short wait times and the convenience of receiving a virtual house call are attractive to patients.

When combined with data showing that telehealth reduces costs in the medical practice, it seems clear there are new options in health care that may improve the bottom line.

Keep the customer satisfied — Mobile health in the orthopedic practice

According to a Beckers Hospital CFO Report, “This direct link between patient satisfaction and revenue will likely become stronger because the U.S. Department of Health and Human Services has set a goal of linking 90% of Medicare payments to quality or value by 2018.”

Although many orthopedic providers continue to express their concern that patients will not be willing to evolve from traditional visits, the most recent research does not hold up this assumption. A 2017 Advisory Board study of patients’ attitudes toward the virtual visits shows 77% would be willing to at least try the model.

The Accenture study highlighted what patients say are the primary benefits of telehealth:

•          faster diagnosis and treatment;

•          reduced costs;

•          providing and receiving high-quality care;

•          more flexibility in scheduling; and

•          time savings for physicians and doctors.

A 2018 article in The New England Journal of Medicine suggests the current model of traditional in-patient visits will eventually be flipped to the visit of last resort over mobile health or telehealth options. The authors suggested, “Face-to-face interactions will certainly always have a central role in health care, and many patients prefer to see their physician in person. However, a system focused on high-quality non-visit care would work better for many others  â€” and quite possibly for physicians as well.”

Some of the systems leading the way are Kaiser Permanente, with 52% of their 100 million-plus patient encounters each year conducted as virtual visits. However, a large health system has the budget to establish telehealth applications while retraining clinical providers and their patients on best practices for using the service. How can a small medical practice find the time and energy to reinvent itself under a mobile health framework?

The answer may lie in the individual practice seeking innovative ways to obtain a competitive advantage. An article by a solo orthopedist in AAOS Now recounted his experience in using telehealth applications to treat postoperative patients. His decision to use the technology was tied to improved patient experience, lower overheads and higher quality of care.

Is it time for your practice to discuss the opportunities to offer mobile health as an option for your patients? OrthoLive has developed a cloud-based affordable telehealth model designed specifically for the orthopedic practitioner. Contact us to find out more.

Source: https://www.healio.com/orthopedics/business-of-orthopedics/news/blogs/%7Bcf0e8b3d-850f-4328-9a71-971b5f29cf36%7D/business-minded-surgeon/blog-consumers-want-mobile-health-convenience

CardioComm Solutions $EKG.ca – #Mhealth Apps Market Size Worth $236.0 Billion by 2026 $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 4:23 PM on Thursday, August 1st, 2019

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

EKG: TSX-V
———————-

mHealth Apps Market Size Worth $236.0 Billion by 2026

  • Global mHealth apps market size is expected to reach USD 236.0 billion by 2026
  • According to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of44.7% during the forecast period

The global mHealth apps market size is expected to reach USD 236.0 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 44.7% during the forecast period. The market is majorly driven by increasing adoption of advanced technologies in healthcare facilities and the need to reduce long waiting periods to access healthcare facilities from specialists. Availability of mobile applications for users is witnessing a rapid growth, especially healthcare apps that assist consumers in self-management of disease, wellness, and chronic conditions. This increased role of patients coupled with the rising importance in staying updated and informed about their own healthcare decisions, contributing to the rise in adoption of mHealth apps globally.

Key suggestions from the report:

  • Rapid growth in chronic diseases along with the rise in the number of app users is accountable for the mHealth apps market growth
  • The types of mHealth apps include fitness, lifestyle management, nutrition and diet, women’s health, medication adherence, healthcare providers, and disease management. Of these, the fitness category accounted for the majority of segment share in 2018
  • mHealth app vendors are focusing their attention on women’s health, diet, and medication reminders. According to Wired, a mobile advertising and analytics platform, women are more inclined toward tracking their health than men
  • Physicians are increasingly recommending the use of mHealth apps to their patients, which is likely to increase the adoption rate of mHealth apps
  • North America led the mhealth applications market in 2018 in terms of revenue share pertaining to the technological advancements and presence of major players in the region

Read More: https://finance.yahoo.com/news/mhealth-apps-market-size-worth-100500547.html

CardioComm Solutions $EKG.ca – Smart healthcare #Mhealth market is poised to grow at an exponential rate $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 11:41 AM on Wednesday, July 31st, 2019

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

EKG: TSX-V
———————-

Market Report on Global Smart Healthcare Market is to Witness Highest Growth in near future Forecast

  • Smart healthcare market is poised to grow at an exponential rate owing to the rapid technological advancements in the healthcare IT, such as development of EHR, mhealth, and telemedicine

Here we have an in-depth study of the Global “Smart Healthcare Market”, which analyzes past as well as recent Smart Healthcare Market values along with detailed market information to capture many factors such as market trends, anticipated future market conditions, challenges, risk and various opportunities during the forecast period from 2018 to the upcoming year 2023. It is precisely stated that data about the Smart Healthcare market will certainly help stakeholders and other business vendors to get a significant understanding of the handling of the Smart Healthcare market globally. All over the world. The report provides a detailed overview of the Smart Healthcare Industry and is then segmented on the basis of product type, key manufacturers, applications and regions.

The global smart healthcare market is projected to grow at a CAGR of 9.2% over the forecast period (2018 – 2023). This report provides information about the leading players in the market and a corresponding detailed analysis of the top vendors in the smart healthcare market. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

The smart healthcare market is poised to grow at an exponential rate owing to the rapid technological advancements in the healthcare IT, such as development of EHR, mhealth, and telemedicine. Also, wearable healthcare devices that are used in tracking and monitoring of health conditions, body temperature, remote cardiac, calories burnt, and sleep statistics are witnessing huge growth. Introduction of technologies such as big data analytics within this sector will drive the prospects for the growth of the healthcare market.

Rapid Technological Advancements are Driving Market Growth

The key factors driving the global smart healthcare market are the rapid technological advancements in the healthcare industry. The development of smart healthcare devices such as smart syringes, smart pills, and smart bandages that are capable of monitoring patient’s healing procedure remotely and minimize the risks involved during the usage of syringes are expected to drive the market growth over the forecast period. However, lack of awareness and constraints related to budget are the factors restraining the growth of the market.

mHealth is Expected to Grow Exponentially over the Forecast Period

The mHealth segment is expected to witness a high growth rate owing to key elements that are leading to its fast development, such as its ability to provide information about the factors that are leading to a disease and reduce overall health risks, rising frequencies of unending infections, for example, tumor, heart diseases, and diabetes. Also, swift advancement and expanding buying power of consumers has brought about proliferation of PDAs, alongside 3G and 4G systems, which is expected to be an essential achievement factor for the development of the worldwide mHealth market.

North America is the Major Contributor for the Market.

The North American market is the highest contributor to smart healthcare owing to the presence of developed IT and healthcare infrastructure and high expenditure on healthcare. The US is the major contributor to the North American market, because of early adoption and huge investment. The Asia-Pacific market is the fastest growing smart healthcare market and is expected to grow at a faster pace during the forecast period as compared to other regions.

Key Developments in the Market

• November 2017 – Cisco and INTERPOL agreed to share threat intelligence as a first step in fighting cybercrimes jointly. This alliance is expected to witness two organizations develop a coordinated and focused approach towards sharing data.
• November 2017 – IBM acquired Vivant Digital Business to address the growing needs of clients seeking transformation though Digital Reinvention.

Source: https://ourcryptojournal.com/new-market-report-on-global-smart-healthcare-market-is-to-witness-highest-growth-in-near-future-forecast-2019-2023/646877/

CardioComm Solutions $EKG.ca – #Mhealth Solutions Market to witness major growth in coming years $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 4:40 PM on Monday, July 22nd, 2019

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment Click here for more info.

Logo large
EKG: TSX-V
————————————-

mhealth Solutions Market to witness major growth in coming years

  • mhealth Solutions Market size is projected to experience significant growth from 2019 to 2025.
  • Growing prevalence of chronic diseases such as blood pressure and cardiac diseases will drive cardiac health related mobile devices growth in the coming years.
  • mHealth technology is viewed as the solution to improve healthcare cost-efficiency as healthcare providers seek to maximize their patient outreach while minimizing costs, thus leading to industry growth.

Increasing penetration of tablet and smart phones users and growing need for remote patient monitoring services will boost mHealth solutions market growth in the future. Increasing demand for healthcare information systems and launch of new applications of mHealth technologies are the factors driving the growth of mHealth solutions market.

Favorable government initiatives will boost mHealth solutions industry in the upcoming years. For instance, in Europe, European commission had launched a public consultation project to gain input from various participant of digital health industry to promote digital health innovations and care for European citizens. Such government initiatives should propel industry growth over the forecast timeframe.

However, lack of lack of favorable reimbursement policies may restrict growth of mHealth solutions market. Highly fragmented mHealth solutions market can hamper revenue generation and company growth in the future.

Glucose meter market will show tremendous growth during the forecast period. Rising incidence of Type-1 and Type-2 diabetes across the globe, increasing usage of homecare devices and growing significance of remote blood glucose monitoring will boost business growth. Moreover, risk of diabetes among the obese individuals and increasing popularity of less invasive glucose monitoring devices has led to rise in demand for digital glucose meters.

Fitness apps market will witness remarkable growth over the forecast period and similar trend is expected in the future. Fitness apps permits consumers to keep a track and monitor on their fitness levels and sports related activities by using smartphones. These apps also help users to keep track on their heart rate and the number of calories lost during workout thus having positive impact on segmental growth.

U.S. will dominate North America mHealth solutions market in the forecast period. U.S. is in forefront for technology adoption. The country is working towards developing smart manufacturing infrastructure that will help operators to make real time use of big data. The implementation of HITECH Act and HIPAA Act are promoting the use of mHealth solution in the country, thus propelling business growth in U.S. during projected timeframe.

Source: http://reportsgo.com/mhealth-solutions-market-to-witness-major-growth-in-coming-years

CLIENT FEATURE: CardioComm Solutions $EKG.ca – Connecting Your Heart To The Cloud $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 9:00 PM on Monday, July 8th, 2019

Global Leader in Mobile  ECG Connectivity

  • 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring  platforms, research groups and commercial call centers
  • Sold into > 20 countries, with the largest customer base located in the US
  • Class II medical device clearances and device agnostic for collecting, viewing, recording, analyzing and  storing of ECGs for management of patient and consumer health
  • ECG solutions for both consumer (OTC) and medical (Rx) markets
  • Owns all IP and source code
  • Market expert contributor for reports in m‐health, mobile cardiac monitoring and new advances in  consumer health and wellness monitoring

Recent Milestones

  • Announced ECG Services Integration and Co-Marketing Agreement with California-Based BodiMetrics LLC
  • CardioComm Solutions GEMS(TM) Universal ECG App Launched in Partnership with Multiple ECG Device Manufacturers
  • Heartcheck(TM) CardiBeat Handheld ECG Device Cleared by Health Canada for Direct-to Consumer Sales

An Innovator in the Mobile ECG Industry

Company Accolades

FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.

CLIENT FEATURE: CardioComm Solutions $EKG.ca – Connecting Your Heart To The Cloud $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 5:04 PM on Monday, May 27th, 2019

Global Leaders in Mobile  ECG Connectivity

  • 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring  platforms, research groups and commercial call centers
  • Sold into > 20 countries, with the largest customer base located in the US
  • Class II medical device clearances and device agnostic for collecting, viewing, recording, analyzing and  storing of ECGs for management of patient and consumer health
  • ECG solutions for both consumer (OTC) and medical (Rx) markets
  • Owns all IP and source code
  • Market expert contributor for reports in m‐health, mobile cardiac monitoring and new advances in  consumer health and wellness monitoring

Recent Milestones

  • Announced ECG Services Integration and Co-Marketing Agreement with California-Based BodiMetrics LLC
  • CardioComm Solutions GEMS(TM) Universal ECG App Launched in Partnership with Multiple ECG Device Manufacturers
  • Heartcheck(TM) CardiBeat Handheld ECG Device Cleared by Health Canada for Direct-to Consumer Sales

Company Accolades

FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.

CardioComm Solutions $EKG.ca Announces ECG Services Integration and Co-Marketing Agreement with California-Based BodiMetrics LLC $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 9:35 AM on Wednesday, May 15th, 2019

Integration of GEMS(TM) Universal ECG App with BodiMetrics hardware platform expands ECG Device Manufacturer’s Offerings to now Include Credible ECG Reporting Services

  • Announced the execution of an ECG and multiple biosign monitoring device integration and co-marketing agreement with California-based BodiMetrics LLC
  • BodiMetrics users can now benefit from access to CardioComm’s trusted ECG report generation and reporting capabilities.
  • BodiMetrics will promote the use of GEMS™ Universal to its extensive customer base and CardioComm will share resultant revenues generated from GEMS™ Universal subscription fees and from paid-for ECG readings.

Toronto, Ontario–(May 15, 2019) – CardioComm Solutions, Inc. (TSXV: EKG) (“CardioComm” or the “Company“), a global provider of consumer heart monitoring and electrocardiogram (“ECG“) acquisition and management software solutions, announces the execution of an ECG and multiple biosign monitoring device integration and co-marketing agreement with California-based BodiMetrics LLC (“BodiMetrics“).

With the launch of CardioComm’s GEMS™ Universal ECG app (“GEMS Universal“), BodiMetrics users can now benefit from access to CardioComm’s trusted ECG report generation and reporting capabilities. BodiMetrics will promote the use of GEMS™ Universal to its extensive customer base and CardioComm will share resultant revenues generated from GEMS™ Universal subscription fees and from paid-for ECG readings. Under the agreement, CardioComm also has distribution rights for the sale of devices through its hospital, telemedicine and consumer sales channels.

GEMS™ Universal will be available under two subscription models:

  • $6 US per month with one free ECG interpretation included; and,
  • $69 US per year with 12 free ECG interpretations that may be requested any time during the one year subscription.


GEMS™ Universal ECG

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/1775/44813_a031f02f84475a0b_001full.jpg

GEMS™ Universal is based directly on the Company’s GEMS™ Mobile ECG and was developed to allow non-HeartCheck™ branded ECG devices users to generate unlimited, medical-grade ECG PDFs or to request a review of their ECG(s) through CardioComm’s SMART Monitoring ECG reading service on a fee-for-review basis. Once the free ECG reviews have been used, additional SMART Monitoring reviews can be requested for $1.99 US for an ECG triage or $12.50 US for a physician interpretation.

The BodiMetrics device replaces five (5) devices with one: ECG, Heart Rate, Systolic Blood Pressure, Blood Oxygenation (Spo2%) and Temperature. BodiMetrics confirms that approximately 30,000 devices have been sold to date with annual sales volumes increasing 50% to 60% each year. US sales occur through Amazon, Best Buy, Costco and various e-commerce channels. Additional sales occur through medical device distributors, Medline, Henry Schein, employer care management partners and telemedicine, patient and virtual care platforms.


BodiMetrics Device

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/1775/44813_a031f02f84475a0b_002full.jpg

A second phase of the agreement will see the GEMS™ Mobile’s ECG management technology embedded directly into BodiMetrics’ device app under a licensing agreement, allowing the user to open only one app to access all existing biometric use options as well as ECG monitoring. Additional information will be provided when the ECG enabled BodiMetrics app is released later this year.

The Company reported the launch of the GEMS™ Universal ECG app on May 14, 2019. The app is now available on Google Play and is scheduled to be available on the App Store within two weeks.

For further updates regarding GEMS™ Mobile ECG device partnerships please see the Companies websites at www.bodimetrics.com, www.theheartcheck.com and www.cardiocommsolutions.com.

About CardioComm Solutions

CardioComm Solutions’ patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. CardioComm Solutions has earned the ISO 13485 certification, is HIPAA compliant and holds clearances from the European Union (CE Mark), the USA (FDA) and Canada (Health Canada).

FOR FURTHER INFORMATION PLEASE CONTACT:

Etienne Grima, Chief Executive Officer
1-877-977-9425 x227
[email protected]
[email protected]

Forward-looking statements

This release may contain certain forward-looking statements and forward-looking information with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. Such statements and information reflect management’s current beliefs and are based on information currently available to management. By their nature, forward-looking statements and forward-looking information involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements and forward-looking information.

In evaluating these statements, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not assume any obligation to update the forward-looking statements and forward-looking information contained in this release other than as required by applicable laws, including without limitation, Section 5.8(2) of National Instrument 51-102 (Continuous Disclosure Obligations).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/44813

CardioComm Solutions’ $EKG.ca Heartcheck(TM) CardiBeat Handheld ECG Device Cleared by Health Canada for Direct-to-Consumer Sales $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 8:46 AM on Thursday, May 9th, 2019

The Bluetooth HeartCheck(TM) CardiBeat and GEMS(TM) Mobile Smartphone App will Target Home, Outpatient, Telemedicine and Cardiac Arrhythmia Monitoring Markets

  • Received approval from Health Canada for the over-the-counter sales and marketing of its existing GEMS™ Mobile smartphone app and for the HeartCheck™ CardiBeat, its newest handheld heart rhythm monitor.
  • Both devices were cleared by the Food and Drug Administration in early 2019.

Toronto, Ontario–(May 9, 2019) – CardioComm Solutions, Inc. (TSXV: EKG) (“CardioComm” or the “Company“), a global provider of consumer heart monitoring and electrocardiogram (“ECG“) acquisition and management software solutions, has received approval from Health Canada for the over-the-counter (“OTC”) sales and marketing of its existing GEMS™ Mobile smartphone app and for the HeartCheck™ CardiBeat, its newest handheld heart rhythm monitor. Both devices were cleared by the Food and Drug Administration (“FDA“) in early 2019.

The Company is very pleased with the rapid approval of the HeartCheck™ CardiBeat ECG monitor application, which was submitted to Health Canada on April 11, 2019. The GEMS™ Mobile Smartphone ECG app is cleared under pre-existing GEMS™ software approvals.

The Bluetooth-enabled and rechargeable CardiBeat easily enables anyone to take a medical-grade ECG recording by simply holding the device in both hands or by holding the device in the right hand and placing it against the left side of their chest. The GEMS™ Mobile app manages ECGs recorded by HeartCheck™ devices and provides near-real-time feedback through the generation of a free ECG report, which can be shared with a physician.

For those looking for feedback on their ECGs, GEMS™ Mobile provides access to CardioComm’s SMART Monitoring ECG reading service. This service provides a professional ECG review to confirm the presence or absence of a number of potential arrhythmias. CardioComm’s ECG pricing is highly competitive compared to other service offerings, and includes a new pricing of U$S1.99 for an ECG Triage offered with a response time as rapid as 30 minutes. ECG connectivity is also possible directly to the Company’s GEMS™ WIN software, which is used by 15 Canadian Hospitals allowing for the opportunity for patients to be monitored directly by physicians and healthcare professionals.

Unlike the US market, availability of personal ECG monitoring devices in Canada is limited, since companies intending to sell such devices must hold ISO certification in compliance with the more demanding Medical Device Single Audit Program (“MDSAP“) requirements. CardioComm completed its MDSAP certification in 2018, thereby solidifying the Company’s abilities to produce and sell its cardiac monitoring software and hardware innovations to consumers and to serve as a preferred importer, distributor and reseller of other manufacturers’ hospital and ECG medical devices.

GEMS™ Mobile is available on Apple’s App Store and on Google Play and is free with the purchase of a HeartCheckTM ECG device.

To learn more about CardioComm’s products please see the Company’s websites at www.theheartcheck.com and www.cardiocommsolutions.com.

About CardioComm Solutions

CardioComm Solutions’ patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. CardioComm Solutions has earned the ISO 13485 certification, is HIPAA compliant and holds clearances from the European Union (CE Mark), the USA (FDA) and Canada (Health Canada).

FOR FURTHER INFORMATION PLEASE CONTACT:

Etienne Grima, Chief Executive Officer
1-877-977-9425 x227
[email protected]

[email protected]

Forward-looking statements

This release may contain certain forward-looking statements and forward-looking information with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. Such statements and information reflect management’s current beliefs and are based on information currently available to management. By their nature, forward-looking statements and forward-looking information involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements and forward-looking information.

In evaluating these statements, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not assume any obligation to update the forward-looking statements and forward-looking information contained in this release other than as required by applicable laws, including without limitation, Section 5.8(2) of National Instrument 51-102 (Continuous Disclosure Obligations).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CLIENT FEATURE: CardioComm Solutions $EKG.ca – Connecting Your Heart To The Cloud $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 11:51 AM on Wednesday, May 8th, 2019

Global Leaders in Mobile  ECG Connectivity

  • 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring  platforms, research groups and commercial call centers
  • Sold into > 20 countries, with the largest customer base located in the US
  • Class II medical device clearances and device agnostic for collecting, viewing, recording, analyzing and  storing of ECGs for management of patient and consumer health
  • ECG solutions for both consumer (OTC) and medical (Rx) markets
  • Owns all IP and source code
  • Market expert contributor for reports in m‐health, mobile cardiac monitoring and new advances in  consumer health and wellness monitoring

FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.

CLIENT FEATURE: CardioComm Solutions $EKG.ca – Connecting Your Heart To The Cloud $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 11:54 AM on Wednesday, May 1st, 2019

Global Leaders in Mobile  ECG Connectivity

  • 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring  platforms, research groups and commercial call centers
  • Sold into > 20 countries, with the largest customer base located in the US
  • Class II medical device clearances and device agnostic for collecting, viewing, recording, analyzing and  storing of ECGs for management of patient and consumer health
  • ECG solutions for both consumer (OTC) and medical (Rx) markets
  • Owns all IP and source code
  • Market expert contributor for reports in m‐health, mobile cardiac monitoring and new advances in  consumer health and wellness monitoring

Company Accolades

FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.